Items tagged with Access
Open letter to Otsuka: continued concerns about delamanid's accessibility (post with simple image)
Leading doctors, advocacy groups and medical organizations remain concerned on several fronts regarding access to delamanid.
Moldova: To save her husband's life, a woman fights for access to TB drugs (post with simple image)
One year ago Pavel Rucsineanu was running out of options.
Countering TB resistance was futile – but no longer (post with simple image)
It was May 23 2010 and 21-year-old Funiwe Mbhamhama woke to the beautiful but forlorn sound of church singing. She looked at the sun streaming in through the crack in the orange curtains of her Khayelitsha home. It wasn't Sunday. There should be no singing.
MSF: Patients in India suffer the consequences of poor regulation of TB drugs (post with simple image)
The ministry of health must act to stop drug resistance from spiralling.
South Africa: "This disease is for heroes. If you can fight this, you can stand anything in this world" (post with simple image)
Siyabulela Qwaka is the latest patient cured of drug resistant TB in MSF’s project in Khayelitsha, South Africa. His story is an inspiration for the others currently fighting the new form of tuberculosis against which existing drugs are of limited effectiveness.
Johnson & Johnson announces new collaboration with Stop TB Partnership’s Global Drug Facility to enhance access to anti-TB compound (post with simple image)
New Brunswick, NJ – April 29, 2014 – Johnson & Johnson today announced that its affiliate Janssen Pharmaceutica NV (Janssen) has entered into a novel collaboration with the Stichting International Dispensary Association (IDA), a procurement agent for the Stop TB Partnership’s Global Drug Facility (GDF), to facilitate access to the Company’s anti-tuberculosis medicine. This public-private partnership was established by the newly formed Janssen Global Public Health and is the latest in the Company’s overall efforts to improve public health.
UNITAID approves grants of $160 million (post with simple image)
Breakthrough new medicines for drug-resistant TB to be made available for low- and middle-income countries as part of $160 million of new grants funded by UNITAID.
End DR-TB patients’ deadly waiting game now, MSF tells SA health authorities (post with simple image)
South Africa could realise savings of up to 42% through fully decentralised models of care, but fragmented, slow government response sees policy stutter after 3 years; MSF negotiates to expand access to effective drugs for more patients at lower price.
South Africa: Litigation threat may prompt access to cheaper DR-TB drug (post with simple image)
South Africa may finally allow access to a cheaper form of the drug-resistant tuberculosis (DR-TB) drug linezolid following the lodging of a high court case.
TB: A dire struggle to keep up on path of increased resistance (post with simple image)
There was recently a small celebration in one of the primary healthcare clinics in Khayelitsha near Cape Town. One more person was officially declared cured after more than two years of treatment for pre-XDR-TB.
Page 54 of 83 · Total posts: 0
←First 53 54 55 Last→